Athanor Capital, LP Cue Biopharma, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$11.2 - $16.09 $187,734 - $269,700	-16,762 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $186,393 - $274,896	16,762 New	16,762 $210,000
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $183,700 - $287,329	-12,206 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.7 - $30.73 $155,016 - $375,090	12,206 New	12,206 $299,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $37.5M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.